352 related articles for article (PubMed ID: 33271763)
21. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
22. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous manifestations of Hyper IgE syndrome.
Minegishi Y; Saito M
Allergol Int; 2012 Jun; 61(2):191-6. PubMed ID: 22441639
[TBL] [Abstract][Full Text] [Related]
24. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
25. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
26. Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients.
Schwierzeck V; Effner R; Abel F; Reiger M; Notheis G; Held J; Simon V; Dintner S; Hoffmann R; Hagl B; Huebner J; Mellmann A; Renner ED
J Clin Immunol; 2022 Aug; 42(6):1301-1309. PubMed ID: 35655107
[TBL] [Abstract][Full Text] [Related]
27. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
[TBL] [Abstract][Full Text] [Related]
29. Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency.
van de Veerdonk FL; Marijnissen RJ; Joosten LA; Kullberg BJ; Drenth JP; Netea MG; van der Meer JW
Clin Exp Immunol; 2010 Jan; 159(1):57-64. PubMed ID: 19878510
[TBL] [Abstract][Full Text] [Related]
30. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
31. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
Patel NC; Gallagher JL; Torgerson TR; Gilman AL
J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
[TBL] [Abstract][Full Text] [Related]
32. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
[TBL] [Abstract][Full Text] [Related]
33. Life-Threatening Pneumopathy and
Deverrière G; Lemée L; Grangé S; Boyer S; Picard C; Fischer A; Marguet C
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562253
[TBL] [Abstract][Full Text] [Related]
34. Staphylococcus aureus Serine protease-like protein A (SplA) induces IL-8 by keratinocytes and synergizes with IL-17A.
De Donato DP; Effner R; Nordengrün M; Lechner A; Darisipudi MN; Volz T; Hagl B; Bröker BM; Renner ED
Cytokine; 2024 Aug; 180():156634. PubMed ID: 38810500
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome.
Minegishi Y; Saito M
Ann N Y Acad Sci; 2011 Dec; 1246():34-40. PubMed ID: 22236428
[TBL] [Abstract][Full Text] [Related]
36. An Update on Syndromes with a Hyper-IgE Phenotype.
Bergerson JRE; Freeman AF
Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
[TBL] [Abstract][Full Text] [Related]
37. Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome.
Farmand S; Kremer B; Häffner M; Pütsep K; Bergman P; Sundin M; Ritterbusch H; Seidl M; Follo M; Henneke P; Henriques-Normark B
Eur J Immunol; 2018 Dec; 48(12):1975-1988. PubMed ID: 30315710
[TBL] [Abstract][Full Text] [Related]
38. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
[TBL] [Abstract][Full Text] [Related]
39. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
